ZyVersa Therapeutics Inc. (ZVSA)
1.38
-0.11 (-7.38%)
At close: Jan 15, 2025, 10:34 AM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 |
| Net Income | -98.30M | -14.05M | -8.08M | -12.68M |
| Depreciation & Amortization | 10.40K | 9.87K | 10.40K | 10.40K |
| Stock-Based Compensation | 1.19M | 3.52M | 4.14M | 3.83M |
| Other Working Capital | 194.51K | 1.67M | -708.45K | 3.71M |
| Other Non-Cash Items | 95.25M | 1.47M | 317.83K | 288.37K |
| Deferred Income Tax | -9.48M | -745.05K | -441.58K | 333.66K |
| Change in Working Capital | 2.60M | 8.29M | -1.02M | 3.11M |
| Operating Cash Flow | -8.72M | -1.49M | -5.08M | -5.11M |
| Capital Expenditures | -1 | n/a | n/a | n/a |
| Acquisitions | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | n/a |
| Investing Cash Flow | n/a | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | n/a | 1.69M |
| Common Stock Repurchased | -10.70M | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -12.15M | 1.96M | 5.23M | -126.40K |
| Financial Cash Flow | 5.96M | 1.87K | 5.23M | 4.56M |
| Net Cash Flow | -2.76M | 370.74K | 153.91K | -549.76K |
| Free Cash Flow | -8.72M | -1.49M | -5.08M | -5.11M |